Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cohen
M Packer
R Gorlin

Circulation

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Circulation|September 1, 1981
Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapyM Packer, J Meller, N Medina, et al.
Circulation|April 1, 1982
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in manM Packer, J Meller, N Medina, et al.
Circulation|August 1, 1975
Main left coronary artery disease. Clinical experience from 1964-1974M V Cohen, R Gorlin
Circulation|August 1, 1990
Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failureM Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
Circulation|December 1, 1989
Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failureM Packer
Circulation|February 1, 1990
Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failureM Packer
Circulation|January 1, 1992
Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failureM Packer
Circulation|September 1, 1975
Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parametersG R Nelson, P F Cohn, R Gorlin
Circulation|February 1, 1986
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failureW H Lee, M Packer
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Circulation|September 1, 1981
Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapyM Packer, J Meller, N Medina, et al.
Circulation|April 1, 1982
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in manM Packer, J Meller, N Medina, et al.
Circulation|August 1, 1975
Main left coronary artery disease. Clinical experience from 1964-1974M V Cohen, R Gorlin
Circulation|August 1, 1990
Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failureM Packer
Circulation|June 1, 1988
Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failureM Packer
Circulation|December 1, 1989
Pathophysiological mechanisms underlying the adverse effects of calcium channel-blocking drugs in patients with chronic heart failureM Packer
Circulation|February 1, 1990
Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failureM Packer
Circulation|January 1, 1992
Lack of relation between ventricular arrhythmias and sudden death in patients with chronic heart failureM Packer
Circulation|September 1, 1975
Prognosis in medically-treated coronary artery disease: influence of ejection fraction compared to other parametersG R Nelson, P F Cohn, R Gorlin
Circulation|February 1, 1986
Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failureW H Lee, M Packer
Pageof 6